Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (59) 59
index medicus (54) 54
cardiovascular (51) 51
female (48) 48
male (48) 48
cardiac & cardiovascular systems (45) 45
middle aged (42) 42
aged (35) 35
treatment outcome (34) 34
abridged index medicus (32) 32
drug-eluting stents (28) 28
stents (26) 26
cardiology (23) 23
internal medicine (23) 23
thrombosis (23) 23
cardiology and cardiovascular medicine (22) 22
heart attacks (22) 22
angioplasty (21) 21
time factors (21) 21
implantation (19) 19
mortality (19) 19
angioplasty, balloon, coronary (18) 18
follow-up studies (18) 18
percutaneous coronary intervention (18) 18
stent (18) 18
transluminal angioplasty (18) 18
coronary vessels (17) 17
sirolimus - analogs & derivatives (17) 17
myocardial infarction (16) 16
sirolimus (14) 14
follow-up (13) 13
myocardial infarction - mortality (13) 13
myocardial infarction - therapy (13) 13
absorbable implants (12) 12
care and treatment (12) 12
coronary angiography (12) 12
everolimus (12) 12
sirolimus - administration & dosage (12) 12
studies (12) 12
bare-metal stents (11) 11
cardiac patients (11) 11
coronary artery disease - therapy (11) 11
electrocardiography (11) 11
heart attack (11) 11
paclitaxel (11) 11
prosthesis design (11) 11
risk factors (11) 11
medicine, general & internal (10) 10
patient outcomes (10) 10
cardiovascular disease (9) 9
denmark - epidemiology (9) 9
drug-eluting stents - adverse effects (9) 9
prospective studies (9) 9
restenosis (9) 9
trial (9) 9
artery-disease (8) 8
denmark (8) 8
diabetes (8) 8
immunosuppressive agents (8) 8
intravascular ultrasound (8) 8
registries (8) 8
analysis (7) 7
clinical outcomes (7) 7
drug-eluting stent (7) 7
heart (7) 7
predictive value of tests (7) 7
prognosis (7) 7
revascularization (7) 7
safety (7) 7
angina pectoris (6) 6
angioplasty, balloon, coronary - methods (6) 6
cardiovascular agents - administration & dosage (6) 6
coronary artery disease (6) 6
coronary artery disease - mortality (6) 6
coronary restenosis (6) 6
coronary vessels - pathology (6) 6
incidence (6) 6
intervention (6) 6
metaanalysis (6) 6
optical coherence tomography (6) 6
reperfusion (6) 6
retrospective studies (6) 6
stent thrombosis (6) 6
aged, 80 and over (5) 5
angiography (5) 5
angioplasty, balloon, coronary - instrumentation (5) 5
angioplasty, transluminal, percutaneous coronary (5) 5
chi-square distribution (5) 5
confidence intervals (5) 5
coronary heart disease (5) 5
lesions (5) 5
myocardial infarction - etiology (5) 5
myocardial infarction - surgery (5) 5
patients (5) 5
percutaneous coronary intervention - methods (5) 5
primary angioplasty (5) 5
regression analysis (5) 5
risk (5) 5
shear-stress (5) 5
stroke (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial
by Bøtker, Hans Erik, Prof and Kharbanda, Rajesh, MD and Schmidt, Michael R, MD and Bøttcher, Morten, MD and Kaltoft, Anne K, MD and Terkelsen, Christian J, MD and Munk, Kim, MD and Andersen, Niels H, MD and Hansen, Troels M, MD and Trautner, Sven, MD and Lassen, Jens Flensted, MD and Christiansen, Evald Høj, MD and Krusell, Lars R, MD and Kristensen, Steen D, MD and Thuesen, Leif, MD and Nielsen, Søren S, MD and Rehling, Michael, MD and Sørensen, Henrik Toft, Prof and Redington, Andrew N, Prof and Nielsen, Torsten T, Prof
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9716, pp. 727 - 734
Summary Background Remote ischaemic preconditioning attenuates cardiac injury at elective surgery and angioplasty. We tested the hypothesis that remote... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | PRECONDITIONING PROTECTS | THROMBUS ASPIRATION | SIZE | THROMBECTOMY | INJURY | REPERFUSION | ARTERY | DEPENDENT MECHANISM | Angioplasty, Balloon, Laser-Assisted | Prospective Studies | Humans | Middle Aged | Tomography, Emission-Computed, Single-Photon | Male | Angioplasty, Balloon, Coronary | Aspirin - administration & dosage | Myocardial Infarction - therapy | Troponin T - blood | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Electrocardiography | Ticlopidine - administration & dosage | Female | Technetium Tc 99m Sestamibi | Drug Therapy, Combination | Radiopharmaceuticals | Echocardiography | Myocardium - pathology | Treatment Outcome | Hospitalization | Ticlopidine - analogs & derivatives | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Arm - blood supply | Ischemic Preconditioning, Myocardial - methods | Myocardial Reperfusion Injury - prevention & control | Care and treatment | Research | Angioplasty | Health aspects | Heart attack | Heart failure | Emergency medical care | Heart attacks | Biomedical research | Statistical analysis | Cardiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Unmatched Results After Double Kissing Crush Stenting Technique in Distal Left Main Coronary Artery Treatment?
by Thuesen, Leif, MD, DMSc and Holm, Niels Ramsing, MD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 10, pp. 1343 - 1345
Cardiovascular | coronary bifurcation | percutaneous coronary intervention | coronary stent(s) | left main coronary artery | coronary revascularization | percutaneous coronary intervention | left main coronary artery | coronary revascularization | CARDIAC & CARDIOVASCULAR SYSTEMS | BIFURCATION LESIONS | FOLLOW-UP | INTERVENTION | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Percutaneous Coronary Intervention - methods | Humans | Female | Male | Stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
by Serruys, Patrick W, Prof and Ormiston, John A, Prof and Onuma, Yoshinobu, MD and Regar, Evelyn, MD and Gonzalo, Nieves, MD and Garcia-Garcia, Hector M, MD and Nieman, Koen, MD and Bruining, Nico, PhD and Dorange, Cécile, MSc and Miquel-Hébert, Karine, PhD and Veldhof, Susan, RN and Webster, Mark, MB and Thuesen, Leif, MD and Dudek, Dariusz, MD
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9667, pp. 897 - 910
Summary Background Drug-eluting metallic coronary stents predispose to late stent thrombosis, prevent late lumen vessel enlargement, hinder surgical... 
Internal Medicine | TRIAL | TOMOGRAPHY | MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | INTRACORONARY ULTRASOUND | ANGIOPLASTY | 3-DIMENSIONAL INTRAVASCULAR ULTRASOUND | IMPLANTATION | ARTERY LESIONS | ATHEROSCLEROTIC PLAQUE COMPOSITION | LUMEN | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Follow-Up Studies | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Clinical Trials as Topic | Absorbable Implants | Drug-Eluting Stents - adverse effects | Multicenter Studies as Topic | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Everolimus | Coronary Restenosis - etiology | Usage | Patient outcomes | Endovascular stents | Studies | Heart attacks | Medical imaging | Stents | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
by Rasmussen, Klaus, MD and Maeng, Michael, MD and Kaltoft, Anne, MD and Thayssen, Per, MD and Kelbæk, Henning, MD and Tilsted, Hans Henrik, MD and Abildgaard, Ulrik, MD and Christiansen, Evald Høj, MD and Engstrøm, Thomas, MD and Krusell, Lars Romer, MD and Ravkilde, Jan, MD and Hansen, Peter Riis, MD and Hansen, Knud Nørregaard, MD and Abildstrøm, Steen Zabell, MD and Aarøe, Jens, MD and Jensen, Jan Skov, MD and Kristensen, Steen Dalby, MD and Bøtker, Hans Erik, Prof and Madsen, Morten, MSc and Johnsen, Søren Paaske, MD and Jensen, Lisette Okkels, MD and Sørensen, Henrik Toft, Prof and Thuesen, Leif, MD and Lassen, Jens Flensted, Dr and SORT OUT III Study Grp and SORT OUT III study group
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9720, pp. 1090 - 1099
Summary Background In low-risk patients, the zotarolimus-eluting stent has been shown to reduce rates of restenosis without increasing the risk of stent... 
Internal Medicine | DRUG | MEDICINE, GENERAL & INTERNAL | THROMBOSIS | IMPLANTATION | LARGE 2-INSTITUTIONAL COHORT | ARTERY LESIONS | DISEASE | ACUTE MYOCARDIAL-INFARCTION | FOLLOW-UP | ENDEAVOR | OUTCOMES | Single-Blind Method | Sirolimus - analogs & derivatives | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Angioplasty, Balloon, Coronary | Drug-Eluting Stents - adverse effects | Retreatment | Thrombosis - etiology | Coronary Disease - therapy | Female | Aged | Myocardial Infarction - etiology | Sirolimus - adverse effects | Care and treatment | Patient outcomes | Dosage and administration | Coronary heart disease | Health aspects | Immunosuppressive agents | Stent (Surgery) | Studies | Intervention | Heart attacks | Medical imaging | Angioplasty | Cardiovascular disease | Clinical medicine | Acute coronary syndromes | Stents | Blood clots
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
by Ormiston, John A, MB and Serruys, Patrick W, Prof and Regar, Evelyn, MD and Dudek, Dariusz, MD and Thuesen, Leif, MD and Webster, Mark WI, MB and Onuma, Yoshinobu, MD and Garcia-Garcia, Hector M, MD and McGreevy, Robert, PhD and Veldhof, Susan, RN
Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9616, pp. 899 - 907
Summary Background A fully bioabsorbable drug-eluting coronary stent that scaffolds the vessel wall when needed and then disappears once the acute recoil and... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MULTICENTER | 6-MONTH | THROMBOSIS | COVERAGE | POLYMER | 1ST HUMAN-EXPERIENCE | FOLLOW-UP | INTRAVASCULAR ULTRASOUND | II TRIAL | INSIGHTS | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Prospective Studies | Humans | Middle Aged | Coronary Restenosis | Male | Absorbable Implants | Angioplasty, Balloon, Coronary | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Safety | Everolimus | Clinical trials | Heart attacks | Angioplasty | Stents | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Five-Year Clinical and Functional Multislice Computed Tomography Angiographic Results After Coronary Implantation of the Fully Resorbable Polymeric Everolimus-Eluting Scaffold in Patients With De Novo Coronary Artery Disease
by Onuma, Yoshinobu, MD and Dudek, Dariusz, MD and Thuesen, Leif, MD and Webster, Mark, MB ChB and Nieman, Koen, MD, PhD and Garcia-Garcia, Hector M., MD, PhD and Ormiston, John A., MB ChB and Serruys, Patrick W., MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2013, Volume 6, Issue 10, pp. 999 - 1009
Objectives This study sought to demonstrate the 5-year clinical and functional multislice computed tomography angiographic results after implantation of the... 
Cardiovascular | everolimus | bioresorbable scaffold | noninvasive functional assessment | multislice computed tomography | FRACTIONAL FLOW RESERVE | CARDIAC & CARDIOVASCULAR SYSTEMS | ATHEROSCLEROTIC PLAQUES | CT ANGIOGRAPHY | BLOOD-FLOW | DIAGNOSTIC-ACCURACY | STENT RECOIL | SHEAR-STRESS | ABSORB TRIAL | INTRAVASCULAR ULTRASOUND | DISCOVER-FLOW
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial
by Maeng, Michael, Dr and Tilsted, Hans Henrik, MD and Jensen, Lisette Okkels, MD and Krusell, Lars Romer, MD and Kaltoft, Anne, MD and Kelbæk, Henning, MD and Villadsen, Anton B, MD and Ravkilde, Jan, MD and Hansen, Knud Nørregaard, MD and Christiansen, Evald Høj, MD and Aarøe, Jens, MD and Jensen, Jan Skov, Prof and Kristensen, Steen Dalby, Prof and Bøtker, Hans Erik, Prof and Thuesen, Leif, MD and Madsen, Morten, MSc and Thayssen, Per, MD and Sørensen, Henrik Toft, Prof and Lassen, Jens Flensted, MD
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9934, pp. 2047 - 2056
Summary Background In head-to-head comparisons of coronary drug-eluting stents, the primary endpoint is traditionally assessed after 9–12 months. However, the... 
Internal Medicine | ANGIOGRAPHIC OUTCOMES | MEDICINE, GENERAL & INTERNAL | REVASCULARIZATION | SCANDINAVIAN ORGANIZATION | SAFETY | BARE-METAL STENTS | NON-INFERIORITY TRIAL | FOLLOW-UP | INTERVENTION | ENDEAVOR-III | ARTERY-DISEASE | Single-Blind Method | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Coronary Restenosis - prevention & control | Cytostatic Agents - administration & dosage | Male | Treatment Outcome | Cytostatic Agents - therapeutic use | Drug-Eluting Stents - adverse effects | Cytostatic Agents - adverse effects | Sirolimus - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Time Factors | Female | Aged | Coronary Thrombosis - etiology | Myocardial Infarction - etiology | Research Design | Sirolimus - adverse effects | Complications and side effects | Usage | Drug-eluting stents | Zotarolimus | Dosage and administration | Research | Health aspects | Comparative analysis | Stent (Surgery) | Transluminal angioplasty | Heart | Cardiology | Studies | Heart attacks | Angina pectoris | Stents | Coronary vessels | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions
by Jensen, Lisette Okkels, MD, PhD and Maeng, Michael, MD, PhD and Kaltoft, Anne, MD, PhD and Thayssen, Per, MD, DMSci and Hansen, Hans Henrik Tilsted, MD and Bottcher, Morten, MD, PhD and Lassen, Jens Flensted, MD, PhD and Krussel, Lars Romer, MD, DMSci and Rasmussen, Klaus, MD, DMSci and Hansen, Knud Noerregaard, MD and Pedersen, Lars, MSc and Johnsen, Soeren Paaske, MD, PhD and Soerensen, Henrik Toft, MD, DMSci, PhD and Thuesen, Leif, MD, DMSci
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 50, Issue 5, pp. 463 - 470
Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions Lisette Okkels Jensen, Michael Mæng, Anne... 
Cardiovascular | Internal Medicine | UNCOATED STENTS | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTATION | SAFETY | POOLED ANALYSIS | COHORT | OUTCOMES | CLINICAL-PRACTICE | ARTERY-DISEASE | Stents - statistics & numerical data | Myocardial Infarction - epidemiology | Drug Delivery Systems - statistics & numerical data | Prospective Studies | Coronary Thrombosis - epidemiology | Follow-Up Studies | Risk Assessment | Comorbidity | Humans | Middle Aged | Male | Cause of Death | Incidence | Outcome and Process Assessment (Health Care) | Denmark - epidemiology | Female | Registries | Aged | Causality | Stents - adverse effects | Drug Delivery Systems - adverse effects | Heart diseases | Thrombosis | Stent (Surgery) | Blood clot | Mortality | Drug therapy | Cardiology | Epidemiology | Heart attacks | Hospitals | Stents | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale
by Fröbert, Ole, MD, PhD and Lagerqvist, Bo, MD, PhD and Gudnason, Thórarinn, MD, PhD, FESC and Thuesen, Leif, MD, PhD and Svensson, Roger, MSci and Olivecrona, Göran K., MD, PhD and James, Stefan K., MD, PhD and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Institutionen för medicinska vetenskaper and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala kliniska forskningscentrum (UCR)
American Heart Journal, ISSN 0002-8703, 2010, Volume 160, Issue 6, pp. 1042 - 1048
Background In ST-elevation myocardial infarction (STEMI), distal embolization of thrombus material often precludes restoration of normal coronary artery flow.... 
Cardiovascular | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTOR | NO-REFLOW | PROTECTION | EMBOLIZATION | THROMBECTOMY | FOLLOW-UP | REPERFUSION | SEGMENT RESOLUTION | X-SIZER | Myocardial Infarction - mortality | Prospective Studies | Double-Blind Method | Follow-Up Studies | Angioplasty, Balloon, Coronary - methods | Humans | Treatment Outcome | Myocardial Infarction - diagnostic imaging | Sweden - epidemiology | Coronary Angiography | Myocardial Infarction - therapy | Thrombectomy - methods | Electrocardiography | Cause of Death - trends | Registries | Suction - methods | Angiography | Angioplasty | Thrombosis | Heart attack | Blood clot | Heart failure | Heart attacks | Medical imaging | Medical technology | Heart surgery | Mortality | Hospitalization | Data bases | Blood clots | Studies | Hypotheses | Coronary vessels | Veins & arteries | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text 10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents
by Galløe, Anders M., MD, PhD and Kelbæk, Henning, MD, DMSc and Thuesen, Leif, MD, DMSc and Hansen, Henrik S., MD, DMSc and Ravkilde, Jan, MD, DMSc and Hansen, Peter R., MD, PhD, DMSc and Christiansen, Evald H., MD, DMSc and Abildgaard, Ulrik, MD, DMSc and Stephansen, Ghita, RN and Lassen, Jens F., MD, PhD and Engstrøm, Thomas, MD, PhD, DMSc and Jensen, Jan Skov, MD, PhD, DMSc and Jeppesen, Jørgen L., MD, DMSc and Bligaard, Niels, MD and SORT OUT II Investigators
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 6, pp. 616 - 624
Abstract Background First-generation drug-eluting coronary stents (DES) were introduced in 2003 to 2004, and their use resulted in a considerable reduction in... 
Cardiovascular | Internal Medicine | coronary disease | stent thrombosis | survival | angioplasty | DRUG | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EFFICACY | THROMBOSIS | SAFETY | BARE-METAL STENTS | FOLLOW-UP | MECHANISMS | IMPLANTATION | Coronary Artery Disease - surgery | Drug-Eluting Stents | Immunosuppressive Agents | Follow-Up Studies | Sirolimus | Humans | Middle Aged | Male | Treatment Outcome | Coronary Restenosis - epidemiology | Time Factors | Paclitaxel | Female | Aged | Graft Occlusion, Vascular - epidemiology | Rapamycin | Stent (Surgery) | Coronary heart disease | Patient outcomes | Heart attacks | Emigration | Values | Cardiovascular disease | Angina pectoris | Thrombosis | Patients | Clinical outcomes | Studies | Confidence intervals | Coronary vessels | Electrocardiography | Acute coronary syndromes | Stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus - and Sirolimus -Eluting Stents (from the SORT OUT IV Trial)
by Jensen, Lisette Okkels, MD, DMSci, PhD and Thayssen, Per, MD, DMSci and Junker, Anders, MD, PhD and Maeng, Michael, MD, PhD and Tilsted, Hans-Henrik, MD and Kaltoft, Anne, MD, PhD and Hansen, Knud Nørregaard, MD and Christiansen, Evald Høj, MD, PhD and Kristensen, Steen Dalby, MD, DMSci and Ravkilde, Jan, MD, DMSci and Madsen, Morten, MSc and Sørensen, Henrik Toft, MD, DMSci, PhD and Thuesen, Leif, MD, DMSci and Lassen, Jens Flensted, MD, PhD
American Journal of Cardiology, The, ISSN 0002-9149, 2012, Volume 110, Issue 11, pp. 1585 - 1591
Diabetes is associated with increased risk of major adverse cardiac events (MACEs) after percutaneous coronary intervention. The purpose of this substudy of... 
Cardiovascular | ANGIOGRAPHY | CARDIAC & CARDIOVASCULAR SYSTEMS | INTRAVASCULAR ULTRASOUND TRIAL | CLINICAL-TRIAL | IMPLANTATION | DEATH | HYPERPLASIA | CORONARY-ARTERY-DISEASE | Coronary Artery Disease - surgery | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Survival Rate - trends | Follow-Up Studies | Angioplasty, Balloon, Coronary - methods | Humans | Middle Aged | Male | Treatment Outcome | Coronary Artery Disease - mortality | Sirolimus - pharmacology | Coronary Artery Disease - complications | Denmark - epidemiology | Female | Retrospective Studies | Diabetes Mellitus - mortality | Everolimus | Immunosuppressive Agents - pharmacology | Diabetics | Care and treatment | Patient outcomes | Diabetes | Angiogenesis inhibitors | Comparative analysis | Cardiology | Stent (Surgery) | Cardiovascular disease | Heart attacks | Stents | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights